Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT05399680

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05399680
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Belgium, France, Italy, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05399680. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-29 (actual); primary completion 2023-09-22 (actual). Results posted on 2025-08-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
Acronym
RADIANCY
Condition
Peripheral Arterial Disease
Intervention (Device)
S.M.A.R.T. RADIANZ™ Vascular Stent System
Intervention (Device)
BRITE TIP RADIANZ™ Guiding Sheath
Intervention (Device)
SABERX RADIANZ™ PTA Balloon Catheter
Lead sponsor
Cordis US Corp. (class: industry)
Collaborator
Qserve (class: industry)
Collaborator
NAMSA (class: other)

Record details

Record id
cardio:ct-nct05399680
Content hash
e1c617891cbbb577e928fbff013d14072a484bdfd994bdacd8f0285161aa29f7